Randomized Phase III Trial of Atezolizumab + Bevacizumab The combination therapy proved efficacious, progression-free survival by PD-L1 group
Aly-Khan Lalani, MD from Dana-Farber Cancer Institute discusses the Randomized Phase III Trial of Atezolizumab + Bevacizumab The combination therapy proved efficacious, progression-free survival by PD...
Author: Genitourinary-Cancer-Meeting
Added: 02/15/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts